Skip to main content
PTGX logo

PTGX · Protagonist Therapeutics, Inc · Analyst Estimates

Track PTGX — free
$140.06 +0.87 (+0.63%) At close · Oct 2
Market Cap
$9.18B
Shares
64.71M
Volume · Oct 2 760.3K Avg daily vol (3M) 634.39K

Analyst Estimates

Compare analyst forecasts for Protagonist Therapeutics, Inc across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-18 06:47 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
3.51804
4.79281
6.0
—
4.46748
4.17331
4.74981
4.17331
— — — —
EPS
analysts
Publication date not stated
— — —
12
— — — —
3
0
9
3
Revenue
USD
Publication date not stated
428500000
542272070
589100000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
12
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-2.8
-0.19915
4.75
—
-0.18838
-0.68465
0.05928
-0.68465
— — — —
EPS
analysts
Publication date not stated
— — —
12
— — — —
4
2
7
1
Revenue
USD
Publication date not stated
67771000
203412140
581600000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
12
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
0.12675
2.59964
3.71
—
2.36279
2.23523
2.48561
2.23523
— — — —
EPS
analysts
Publication date not stated
— — —
11
— — — —
3
0
6
2
Revenue
USD
Publication date not stated
95000000
243365550
292000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
11
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.9
-0.43265
0.55
—
-0.07821
-0.16932
-0.3925
-0.16932
— — — —
EPS
analysts
Publication date not stated
— — —
10
— — — —
4
1
4
2
Revenue
USD
Publication date not stated
2652000
36267560
162100000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
9
— — — — — — — —
Key facts CIK 1377121 CUSIP 74366E102 13F (30d) 8 filings 8 filers Visit website Investor relations